{
    "Trade/Device Name(s)": [
        "SYNCHRON\u00ae Systems G7 Amylase (AMY7) Reagent"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K091846",
    "Predicate Device Reference 510(k) Number(s)": [
        "K070064"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JFJ"
    ],
    "Summary Letter Date": "September 11, 2009",
    "Summary Letter Received Date": "September 14, 2009",
    "Submission Date": "June 19, 2009",
    "Regulation Number(s)": [
        "21CFR862.1070"
    ],
    "Regulation Name(s)": [
        "Amylase test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Amylase"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "SYNCHRON LX",
        "UniCel DxC 600",
        "UniCel DxC 800",
        "SYNCHRON CX PRO Clinical Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic rate method",
        "Absorbance measurement at 410 nm"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for SYNCHRON Systems G7 Amylase (AMY7) Reagent for quantitative determination of total amylase activity using an enzymatic rate method",
    "Indications for Use Summary": "Intended for quantitative determination of total amylase activity in human serum, plasma or urine to aid in diagnosis and treatment of pancreatitis",
    "fda_folder": "Clinical Chemistry"
}